Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL™ Sickle Cell Disease Module

Health and Quality of Life Outcomes

Volumn 15, Issue 1, 2017, Pages

  Panepinto, Julie A ^a   Paul Scott, J ^a   Badaki Makun, Oluwakemi ^b   Darbari, Deepika S ^c   Chumpitazi, Corrie E ^d   Airewele, Gladstone E ^d   Ellison, Angela M ^e   Smith Whitley, Kim ^e   Mahajan, Prashant ^f   Sarnaik, Sharada A ^f   Charles Casper, T ^g   Cook, Larry J ^g   Leonard, Julie ^h   Hulbert, Monica L ⁱ   Powell, Elizabeth C ^j   Liem, Robert I ^k   Hickey, Robert ^l   Krishnamurti, Lakshmanan ^m   Hillery, Cheryl A ⁿ   Brousseau, David C ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^g UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^h NATIONWIDE CHILDREN S HOSPITAL   (United States)

ⁱ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j NORTHWESTERN UNIVERSITY   (United States)

^k CHILDREN'S MEMORIAL HOSPITAL   (United States)

^l CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^m EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Acute pain crises; Longitudinal validity; Quality of life; Responsiveness; Sickle cell disease

Indexed keywords

HYDROXYUREA;

ADULT; AGE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ERROR; OUTCOME ASSESSMENT; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; SEX DIFFERENCE; SICKLE CELL ANEMIA; ADOLESCENT; CLINICAL TRIAL; HEALTH STATUS; MULTICENTER STUDY; PAIN; PRESCHOOL CHILD; PROSPECTIVE STUDY; PSYCHOLOGY; VALIDATION STUDY; YOUNG ADULT;

ADOLESCENT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH STATUS; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PROSPECTIVE STUDIES; QUALITY OF LIFE; YOUNG ADULT;

EID: 85020437622     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-017-0700-2     Document Type: Article

References (17)

1. Panepinto JA, Bonner M. Health-related quality of life in sickle cell disease: past, present, and future. Pediatr Blood Cancer. 2012;59(2):377-85.
2. Panepinto JA, Torres S, Bendo CB, McCavit TL, Dinu B, Sherman-Bien S, et al. PedsQL sickle cell disease module: feasibility, reliability, and validity. Pediatr Blood Cancer. 2013;60(8):1338-44.
3. Brousseau DC, Scott JP, Badaki-Makun O, Darbari DS, Chumpitazi CE, Airewele GE, et al. A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children. Blood. 2015;126(14):1651-7.
4. Badaki-Makun O, Scott JP, Panepinto JA, Casper TC, Hillery CA, Dean JM, Brousseau DC, Pediatric Emergency Care Applied Research Network Magnesium in Sickle Cell Crisis Study G: Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial. Pediatr Blood Cancer 2014, 61(6):1049-1054.
5. Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the pediatric quality of life inventory generic core scales, multidimensional fatigue scale, and cancer module. Cancer. 2002;94(7):2090-106.
6. Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK. Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes. 2006;4:70.
7. Cohen LaH M. Statistics for social scientists. London: Harper and Row; 1982.
8. Wyrwich KW, Nienaber NA, Tierney WM, Wolinsky FD. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care. 1999;37(5):469-78.
9. Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol. 1999;52(9):861-73.
10. King MT. A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res. 2011;11(2):171-84.
11. Panepinto JA, O'Mahar KM, DeBaun MR, Rennie KM, Scott JP. Validity of the child health questionnaire for use in children with sickle cell disease. J Pediatr Hematol Oncol. 2004;26(9):574-8.
12. Panepinto JA, Pajewski NM, Foerster LM, Sabnis S, Hoffmann RG. Impact of family income and sickle cell disease on the health-related quality of life of children. Qual Life Res. 2009;18(1):5-13.
13. FDA. Guidance for Industry: Patient-reported outcome measures: Use in medical product development to support labeling claims [ http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071975.pdf ].
14. Cappelleri JC, Bushmakin AG. Interpretation of patient-reported outcomes. Stat Methods Med Res. 2014;23(5):460-83.
15. Johnston BC, Ebrahim S, Carrasco-Labra A, Furukawa TA, Patrick DL, Crawford MW, et al. Minimally important difference estimates and methods: a protocol. BMJ Open. 2015;5(10):e007953.
16. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102-9.
17. Wyrwich KW, Norquist JM, Lenderking WR, Acaster S, Industry Advisory Committee of International Society for Quality of Life R. Methods for interpreting change over time in patient-reported outcome measures. Qual Life Res. 2013;22(3):475-83.